AAV based SARM1 gene therapy (Disarm Therapeutics)

N/A

Report date: 2025/03/14 16:40:27

Base Information

Drug NameAAV based SARM1 gene therapy (Disarm Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNAD(+) hydrolase SARM1 inhibitors
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsPeripheral Nervous System DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDisarm Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDisarm Therapeutics
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A